What is the Impact Factor of Journal of Cardiovascular Translational Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Cardiovascular Translational Research is 2.60, ranking in quartile Q2 of Web of Science (SCIE).

Is Journal of Cardiovascular Translational Research indexed in Web of Science or Scopus?

Yes, Journal of Cardiovascular Translational Research is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.802 (Q1) and an H-index of 68.

Who publishes Journal of Cardiovascular Translational Research and what is the Article Processing Charge (APC)?

Journal of Cardiovascular Translational Research is published by Springer US. The estimated Article Processing Charge (APC) is approximately $3,200 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Cardiovascular Translational Research?

The official ISO-4 abbreviation of Journal of Cardiovascular Translational Research is "J CARDIOVASC TRANSL" with common acronym "catr". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #6,885Hybrid

Journal of Cardiovascular Translational Research

Acronym:catr

•

Abbreviation (ISO):J CARDIOVASC TRANSL

•

Identifier (ISSN):1937-5387(Print)/1937-5395(Online)

•

Publisher:Springer US

Official Website Submission Portal Compare

Clarivate IF (2026)

2.6↑ +0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Cardiovascular Translational Research

WoS Q2

Annual Impact Factor Metric

Current (2026):2.6

Scopus SJR & RankScopus Q1

0.802

#6,885

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

68 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4.2%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

95articles/year

29.85% Gold OA•75.37% Original Research

Aims & Scope

Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research. JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

Topics Covered (Recognized by AI)

Medicine96.6%Internal medicine88.9%Biology86%Cardiology70.6%Chemistry58.6%Genetics56.2%Biochemistry55.6%Pathology45.3%Psychology44.1%Endocrinology39.8%Psychiatry37.5%Surgery36.4%Heart failure30%Radiology28.6%Cell biology28%Gene27.9%Myocardial infarction23.9%Bioinformatics20.8%

Primary Research Areas

Cardiac & Cardiovascular Systems Medicine Research & Experimental

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Rank106/237

IndexSCIE

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank109/191

IndexSCIE

JCISCIE2026

CARDIAC & CARDIOVASCULAR SYSTEMS

Rank111/237

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank95/191

IndexSCIE

Category	Index	Rank	Quartile
CARDIAC & CARDIOVASCULAR SYSTEMS	JCRSCIE	106/237	Q2
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	109/191	Q3
CARDIAC & CARDIOVASCULAR SYSTEMS	JCISCIE	111/237	Q2
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	95/191	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.6

Articles / Year114

Total Citations25

2025

IF2.5

Articles / Year135

Total Citations348

2024

IF2.4

Articles / Year111

Total Citations492

2023

IF3.4

Articles / Year128

Total Citations963

2022

IF3.216

Articles / Year151

Total Citations1,678

Year	Impact Factor	Articles / Year	Total Citations
2026	2.6	114	25
2025	2.5	135	348
2024	2.4	111	492
2023	3.4	128	963
2022	3.216	151	1,678
2021	4.132	100	1,378
2020	3.312	141	3,169
2019	2.756	90	1,879
2018	2.337	77	2,528
2017	—	52	1,565
2016	—	58	1,681
2015	—	62	1,374

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,885Scopus Q1SCImago Profile

Scopus Coverage:2008-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.802

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.70

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,200 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,110

3-Year Documents400

Citable Documents369

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

Cardiology and Cardiovascular MedicineQ2

GeneticsQ2

Genetics (clinical)Q2

Molecular MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区CARDIAC & CARDIOVASCULAR SYSTEMS

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Cardiovascular Translational Research (acronym: catr, abbr: J CARDIOVASC TRANSL, ISSN: 1937-5387) is a peer-reviewed international scholarly journal in the field of CARDIAC & CARDIOVASCULAR SYSTEMS, published by Springer US in United States since 2008. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.802 (Q1), an H-index of 68.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 95 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,200 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.